Europe midday: Stoxx slips as Trump pressures Zelenskyy ahead of talks

European shares slipped into negative territory at midday on Monday as US President Donalkd Trump effectively sided with Russia and pressured Ukraine leader Volodymyr Zelenskyy to accept a peace deal ahead of a crunch meeting in Washington between the two men and European leaders to discuss ending the conflict.

Source: Sharecast

The pan-regional Stoxx 600 index was down 0.11% at 552. Germany’s DAX declined 0.39% and France’s CAC 40 fell 0.19%, while the UK’s FTSE 100 gave up morning gains to be 0.05% lower.

Sentiment was hit when Trump, who has largely aligned the US with Russia, said overnight that Zelenskyy could end the war with Russia “almost immediately, if he wants to, or he can continue to fight”.

He also ruled out Ukraine joining Nato or regain Crimea – a key demand from Moscow. The meeting follows Trump’s short summit with Russian leader Vladimir Putin in Alaska on Friday, which ended without a ceasefire.

Zelenskyy will be joined by German Chancellor Friedrich Merz, French President Emmanuel Macron and UK Prime Minister Keir Starmer.

“The future of Ukraine hangs heavy in the balance as Zelenskyy, flanked by European leaders, prepares to meet Trump. Putin’s high bar for a peace deal may scupper hopes for an end to the conflict, but with more details emerging about what land could be ceded or retained in Eastern Ukraine, there does seem be more substance to the talks,” said Hargreaves Lansdown analyst Susannah Streeter.

There was a dearth or corporate news to drive trade in the middle of the August holiday period. Shares in UK food producer Cranswick were down after new allegations of cruelty towards piglets at another of its farms emerged on the weekend.

Vestas shares surged more than 16.4% to top the Stoxx after the US Treasury published guidelines for the qualification of wind and solar subsidies for projects to 2030. The news boosted other renewables shares, with EDP Renonvaveis, Orsted and RWE all higher.

Novo Nordisk jumped as the drugmaker's weight-loss drug Wegovy received an accelerated approval by the US Food and Drug Administration to treat a serious liver condition.

Reporting by Frank Prenesti for Sharecast.com

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Bank of Scotland is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Bank of Scotland Share Dealing Service is operated by Halifax Share Dealing Limited. Halifax Share Dealing Limited. Registered in England and Wales No. 3195646. Registered Office: Trinity Road, Halifax, West Yorkshire HX1 2RG. Authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2025 Refinitiv, an LSEG business. All rights reserved.